Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

SEC digs into Pfizer's overseas profits, tax reductions

This article was originally published in Scrip

Executive Summary

Pfizer had some "splainin' to do" when the Securities & Exchange Commission (SEC) said the pharma giant's reported domestic operations pre-tax losses of $2.2 billion in the US in 2011, with international operations producing pre-tax earnings of $15 billion, didn't quite jibe with what the firm reported for domestic and international revenues, which that year were $26.9 billion and $40.5 billion, respectively.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC019050

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel